Русские видео

Сейчас в тренде

Иностранные видео


Скачать с ютуб Bringing Mesenchymal Stromal Cells into the Clinic| REPROCELL в хорошем качестве

Bringing Mesenchymal Stromal Cells into the Clinic| REPROCELL 2 недели назад


Если кнопки скачивания не загрузились НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием, пожалуйста напишите в поддержку по адресу внизу страницы.
Спасибо за использование сервиса savevideohd.ru



Bringing Mesenchymal Stromal Cells into the Clinic| REPROCELL

Mesenchymal stromal cells (MSCs; also called Mesenchymal Stem Cells) are multipotent adult stem cells that have been defined and studied for several decades for their clinical potential. Indeed, these cells continue to be the source of numerous clinical trials, and interest in their use for therapeutic purposes continues to grow. Allogeneic MSCs are particularly interesting for their favorable safety profile, thanks to their low immunogenic potential and their multiple beneficial properties. Indeed, they have the ability to self-renew and differentiate into multiple cell lineages, including bone, chondrocytes, adipocytes, and cardiomyocytes, making them an attractive source for cell-based regenerative therapies. MSCs also have an immunomodulatory and anti-inflammatory effect on innate and adaptive immune cells. As inflammation is considered the primary cause of many diseases, the anti-inflammatory property plays an essential role in the therapeutic use of MSCs. Moreover, these cells can be isolated from almost any vascularized tissue, including bone marrow, adipose tissue, and umbilical cord. Despite the promising results accumulated over the years and in clinical trials, few companies worldwide have been able to produce and market MSCs as a cell therapy. CellColabs is positioned as one of the world leaders in the large-scale production of affordable allogeneic MSCs. Throughout the production process, our cellular product undergoes rigorous quality control, including tests to ensure the sterility, purity, viability, and activity of the cells. Our MSCs has thus obtained the authorization for clinical use of the cells in the Bahamas and the Maldives, where patients have benefited from our cell therapy for the treatment of pathologies such as knee arthritis, sports injuries, preventive and aging frailty, and cardiovascular disease. Moving forward, our focus remains on expanding and diversifying our sources of MSCs to meet the escalating demand for Good Manufacturing Practice (GMP)-compliant stem cells within the healthcare sector. Through continued innovation and dedication to excellence, we are poised to address the evolving needs of patients and healthcare professionals worldwide.https://www.reprocell.com/ ____________________________________________________________________________ Follow us on LinkedIn:   / reprocell   Follow us on Twitter:   / reprocellglobal   ____________________________________________________________________________ Browse our product catalog: https://www.reprocell.com/product-cat... Got a research project you are looking to outsource? Contact our scientists to arrange a free consultation: https://www.reprocell.com/contact

Comments